APA (7th ed.) Citation

Flori, L., Brogi, S., Sirous, H., & Calderone, V. (2023). Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes. International Journal of Molecular Sciences, 24(8), 7578. https://doi.org/10.3390/ijms24087578

Chicago Style (17th ed.) Citation

Flori, Lorenzo, Simone Brogi, Hajar Sirous, and Vincenzo Calderone. "Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes." International Journal of Molecular Sciences 24, no. 8 (2023): 7578. https://doi.org/10.3390/ijms24087578.

MLA (9th ed.) Citation

Flori, Lorenzo, et al. "Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes." International Journal of Molecular Sciences, vol. 24, no. 8, 2023, p. 7578, https://doi.org/10.3390/ijms24087578.